ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001654954-18-005414
| Metric | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|
| Revenue | $6.17K | $0.00 | — |
| Net Income | -$2.83M | -$741.62K | -$379.48K |
| EPS Diluted | -$0.72 | -$1.03 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
